At a glance
We’re excited to see you in San Francisco!
Stop in at booth 1009 to connect with our team and learn how Veracyte is using whole-transcriptome-derived analysis on every sample to generate a wealth of information and create the potential for novel research.
Veracyte’s Medical Director of Endocrinology Dr. Klopper will present in Science and Innovation Theater #1 on Sunday, July 13th, 2:30 – 3:30 PM (PT).
In this presentation, Dr. Klopper will describe how Afirma’s whole-exome molecular analysis provides accurate and reproducible results to help in thyroid nodule management and represents a platform for novel research opportunities.
Product Theatre / Special Sessions
| Title | Session | Date | Time | Presenter(s) | Location |
|---|
A presentation on how Afirma’s whole-exome molecular analysis provides accurate and reproducible results to help in thyroid nodule management and represents a platform for novel research opportunities. | Product Theatre | Sunday, July 13 | 2:30 – 3:30 PM PT | Dr. Josh Klopper, M.D. | Science and Innovation Theater #1 |
Retinoic Acid Receptor (RAR) and Retinoid X Receptor (RXR) Expression in Preoperative Thyroid Tumor Samples (MON-392) | Product Theatre | Monday, July 14 | 12:00 – 1:30 PM PT | – | – |
Development of a Prognostic Cell Cycle Progression Score in Preoperative Thyroid Tumor Samples to Predict Prognosis (MON-380) | Product Theatre | Monday, July 14 | 12:00 – 1:30 PM PT | – | – |
Vitamin D Signaling Expression Markers in Thyroid Tumors (MON-379) | Product Theatre | Monday, July 14 | 12:00 – 1:30 PM PT | – | – |
Tags
North America
Afirma Thyroid
Afirma GRID